Clinical Trials
3 trialsNCT01321879 2019-12-27
Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02774850 2019-12-23
Aim 1
Children's Hospital of Philadelphia
Completed
NCT00398411 2015-06-29
MoxiProph
University of Cologne
Phase 3 Completed